Mariner’s Alpha Tau Medical DRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding DRTS
GIA
BFM
AF
PC
AC
AIM
Mariner's DRTS Position: Q2 2026 in Review
Mariner increased its Alpha Tau Medical (DRTS) stake by 14% in Q2 2026, buying an estimated $188K and bringing the position to 167,086 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1464.
Mariner first reported a position in DRTS in Q4 2023 and has held it in 11 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.
- Mariner held 167,086 shares of Alpha Tau Medical worth $2.1M as of Q2 2026.
- Mariner bought 20,690 Alpha Tau Medical shares in Q2 2026, an estimated $188K.
- Alpha Tau Medical made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1464 holding.
- Mariner first reported a position in Alpha Tau Medical in Q4 2023 and has held it in 11 quarters since.
- 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.
Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.